Anti-SARS-CoV-2 Nucleocapsid humanized Antibody, clone 5B7 by The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada

SARS-CoV-2 Nucleocapsid, clone 5B7 Monoclonal Antibody (matched pair with clone 4D8)


Anti-SARS-CoV-2 Nucleocapsid humanized Antibody, clone 5B7 by The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada product image
Anti-SARS-CoV-2 Nucleocapsid humanized Antibody, clone 5B7
Request Pricing

The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antibody can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).